The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


One-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a propensity score comparison of patients enrolled in the ABSORB EXTEND and SPIRIT trials

EuroIntervention 2016;12:1255-1262. DOI: 10.4244/EIJV12I10A206

1. Instituto de Cardiologia Dante Pazzanese, Sao Paulo, Brazil; 2. Centro Cardiologico Monzino, IRCCS, University of Milan, Milan, Italy; 3. St Vincent’s Hospital, Fitzroy, Victoria, Australia; 4. Prince of Wales Public Hospital, Sydney, Australia; 5. Soc

Aims: We sought to compare the outcomes of low/moderate complexity patients treated with the Absorb BVS from the ABSORB EXTEND trial with patients treated with the XIENCE everolimus-eluti

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Endothelial dysfunction and the occurrence of radial artery spasm during transradial coronary procedures: the ACRA-Spasm study